Personalised Medicine (PM) is one of the most innovative areas in the future of health research. Its high
potential, for patients, citizens and the economy is not being fully realised due to fragmented activities,
insufficient communication and lack of generic solutions. The implementation of PM is therefore a key
challenge in Europe and beyond.
The EU-funded Coordination & Support Action PerMed was initiated to step up stakeholder coordination
to allow synergies and avoid duplication or competition, and ensure maximum transparency to equip
Europe to lead the world. Its aim is to develop recommendations to foster the implementation of PM in
transnational research and health systems.